|« Previous month||Next month »|
31-Jul-2013 - EMD Millipore has become the first major drug excipient supplier to pass IPEC Federation’s Excipact certification scheme .
31-Jul-2013 - The US FDA has amended the list of draft guidance documents it expects to release for the rest of the year with two new guidance topics, one deleted guidance and...
31-Jul-2013 - Medicines New Zealand has merged with the Vaccines Industry Association of New Zealand (VIANZ) in order to share resources and provide a single point of contact for all stakeholders.
30-Jul-2013 - Valeant says it will slash its workforce by up to 15% and consolidate some of its non-US locations following the acquisition of Bausch & Lomb.
30-Jul-2013 - Codexis and Purolite have teamed up to create immobilized enzymes they say can speed up active pharmaceutical ingredient (API) development.
30-Jul-2013 - Management and staff involved in manipulating quality data during an FDA inspection have been sacked by Fresenius Kabi as part of remediation actions at its Indian API facility.
30-Jul-2013 - Catalent has completed the purchase of a Chinese softgel firm following regulatory approval.
30-Jul-2013 - Newly rejigged Pfizer has licensed a cell line tech developed by Lonza and BioWa for use in its therapeutic antibody programme.
29-Jul-2013 - Plans to make fees drugmakers pay the US FDA in future exempt from mandatory Government spending cuts have been welcomed by industry groups.
29-Jul-2013 - Amidst accusations of widespread bribery and corruption in China, GlaxoSmithKline has appointed Herve Gisserot as its new head of business in the country.
29-Jul-2013 - NovaMedica and the Russian Government are to build an $85m (€64m) facility as part of a joint venture encouraging local manufacturing, the company says.
25-Jul-2013 - Tasi Group has acquired pharmaceutical leak testing firm Sepha and plans to seek more customers overseas.
25-Jul-2013 - Australian firm Ascent Pharmaceuticals has issued a recall of one batch of paracetamol after concerns bottles may contain a foreign tablet.
25-Jul-2013 - Aesica has licensed an anti-abuse technology from QRxPharma that it claims outperforms all other solutions currently on the market.
25-Jul-2013 - Lonza says developing biosimilars with Teva would have been too costly and any biologics produced would have taken too long to bring to market.
24-Jul-2013 - Europe may soon approve the first biologic made according to quality by design (QbD) principles, but opinions are still split over whether the approach should even be applied to biopharmaceuticals.
24-Jul-2013 - Biopharma firms, particularly those producing insulin and five of its analogues, have another option in the market of sub-2 micron solid-core chromatography columns with a recent offering from Waters.
24-Jul-2013 - Appreciating warm alcohol, like being rubbish at cricket, is no longer a solely British preserve with researchers in Australia developing a hot ethanol-based manufacturing method that, they claim, produces smaller,...
24-Jul-2013 - Industry bodies say they support the sharing of trial data following allegations yesterday they used patient groups to lobby new EU transparency regulations.
24-Jul-2013 - Dry powder inhaler firms may soon be able to eliminate lactose from formulations if a new high dispersibility particle production platform is successful in trials.
23-Jul-2013 - The EFPIA and PhRMA are targeting an "army" of patient groups to lobby EU plans to publish clinical trial data, according to a leaked memo.
23-Jul-2013 - The current US shortage of tetracycline is not likely to be resolved any time soon because of ongoing manufacturing and raw material supply issues according to the US FDA.
23-Jul-2013 - Johnson & Johnson’s troubled Fort Washington plant may reopen early next year, says the firm following a $23m lawsuit settlement.
23-Jul-2013 - GlaxoSmithKline (GSK) announced Monday a few of its senior executives may have breached China law as reports of a bribery scandal continue to surface.
22-Jul-2013 - Import duties on some pharma intermediates could be suspended temporarily under legislation being debated in the US House of Representatives.
|« Previous month||Next month »|